John Dawson named Executive of the Year for Companies <$10bn at the Annual Scrip Awards 2020
-Ends- Oxford, UK – 3 December, 2020: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), a leading gene and cell therapy group, is pleased to announce that, John Dawson,…